Related Experiment Videos
Predisposition towards urolithiasis associated with the NQO1 null-allele
W A Schulz1, A Krummeck, I Rösinger
1Institut für Physiologische Chemie I, Düsseldorf, Germany.
Pharmacogenetics
|November 24, 1998
Summary
The NQO1 null-allele, linked to reduced enzyme activity, is more common in kidney stone patients, suggesting it increases urolithiasis risk.
Area of Science:
- Genetics
- Biochemistry
- Urology
Background:
- Kidney stones (urolithiasis) pose a significant health burden.
- The NADP(H):quinone oxidoreductase (NQO1) enzyme plays a role in cellular protection and vitamin K metabolism.
- Genetic variations in NQO1 may influence susceptibility to stone formation.
Purpose of the Study:
- To investigate the association between NQO1 gene alleles and the risk of developing kidney stones.
- To explore the potential role of NQO1 enzyme activity in the pathogenesis of urolithiasis.
Main Methods:
- Genotyping for NQO1 alleles in 140 urolithiasis patients and 271 controls.
- Statistical analysis to compare allele frequencies and calculate odds ratios.
- Literature review on NQO1 function and vitamin K-dependent protein carboxylation.
Main Results:
- The NQO1 null-allele was significantly more frequent in urolithiasis patients (q=0.214) compared to controls (p=0.135).
- Heterozygotes and homozygotes for the null-allele showed increased odds of kidney stone formation (OR 1.83 and 2.97, respectively).
- Reduced NQO1 activity may impair vitamin K activation, affecting calcium-binding proteins crucial for preventing kidney stones.
Conclusions:
- The NQO1 null-allele is associated with an elevated risk of kidney stone formation.
- Impaired post-translational modification of urinary calcium-binding proteins due to decreased NQO1 activity may contribute to urolithiasis.
- NQO1 genotype could be a determinant factor in the enhanced risk of urolithiasis.